We are live on ! Find out more
PROK icon

ProKidney
PROK

56 hedge funds and large institutions have $446M invested in ProKidney in 2023 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 20 increasing their positions, 3 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,225% more call options, than puts

Call options by funds: $106K | Put options by funds: $8K

567% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 3

350% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 6

60% more funds holding

Funds holding: 35 → 56 (+21)

14% more capital invested

Capital invested by funds: $391M → $446M (+$54.4M)

8.48% more ownership

Funds ownership: 56.17% → 64.65% (+8.5%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
56
Holders Change
+21
Holders Change %
+60%
% of All Funds
0.88%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
27
Increased
20
Reduced
3
Closed
6
Calls
$106K
Puts
$8K
Net Calls
+$98K
Net Calls Change
-$33K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$32M
2
State Street
State Street
Massachusetts
+$9.9M
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$6.63M
4
Northern Trust
Northern Trust
Illinois
+$4.5M
5
Nuveen
Nuveen
North Carolina
+$2.24M

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$11.6M
2
Millennium Management
Millennium Management
New York
-$1.16M
3
HF
HRT Financial
New York
-$730K
4
UOC
UBS O'Connor
Illinois
-$564K
5
Squarepoint
Squarepoint
New York
-$293K

PROK Hedge Fund Activity: Q2 2023 in Review

56 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in ProKidney (PROK) for Q2 2023, worth a combined $446M — up 14% from $391M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new PROK positions and 6 closed out — a net gain of 21 holders — while 20 added to existing stakes and 3 trimmed.

The largest buyer was BlackRock, adding an estimated $32M. The largest seller was Vanguard Group, cutting an estimated $11.6M.

  • 56 institutional investors held ProKidney (PROK) as of Q2 2023, up from 35 in Q1 2023.
  • Funds reported $446M of ProKidney stock for Q2 2023, up 14% quarter-over-quarter.
  • 27 funds opened new ProKidney positions in Q2 2023 and 6 closed out, a net change of +21 holders.
  • The largest ProKidney buyer in Q2 2023 was BlackRock, an estimated $32M added.
  • The largest ProKidney seller in Q2 2023 was Vanguard Group, an estimated $11.6M sold.

Based on aggregated 13F filings for Q2 2023.